This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Chinese Community Smoking Cessation Project

This study has been completed.
Sponsor:
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by:
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT00139516
First received: August 29, 2005
Last updated: March 11, 2014
Last verified: March 2014
  Purpose

The study has two objectives/aims:

Aim 1: To test the efficacy of the intervention among adult smokers with cardiovascular disease, pulmonary disease and diabetes mellitus related illnesses (later modified to Chinese adults with and without diseases); and

Aim 2: To examine a set of measures (background, general health, psychosocial, and smoking process) that are associated with smoking cessation at 6 and 12 months


Condition Intervention
Cardiovascular Diseases Heart Diseases Lung Diseases Diabetes Mellitus Chronic Obstructive Pulmonary Disease Behavioral: self-help Drug: nicotine replacement therapy Behavioral: smoking cessation

Study Type: Interventional
Study Design: Allocation: Randomized
Primary Purpose: Prevention

Resource links provided by NLM:


Further study details as provided by University of California, San Francisco:

Study Start Date: September 2001
Study Completion Date: August 2007
Primary Completion Date: August 2007 (Final data collection date for primary outcome measure)
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • having smoked a cigarette, cigar, or tobacco pipe during the 3 months preceding the baseline interview
  • reside in the San Francisco Bay Area at baseline
  • must be fluent in either English or Chinese (Mandarin or Cantonese)
  • be 18 and over in age and
  • not currently engaging in assisted smoking cessation efforts

Exclusion criteria

  • unable to speak English or Chinese
  • too ill to participate, or not willing to participate in smoking cessation effort
  • pregnancy
  • major psychiatric illness not under control/treatment
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00139516

Sponsors and Collaborators
University of California, San Francisco
National Heart, Lung, and Blood Institute (NHLBI)
Investigators
OverallOfficial: Candice Wong University of California at San Francisco
  More Information

ClinicalTrials.gov Identifier: NCT00139516     History of Changes
Other Study ID Numbers: 247
R01HL069363 ( U.S. NIH Grant/Contract )
Study First Received: August 29, 2005
Last Updated: March 11, 2014

Additional relevant MeSH terms:
Diabetes Mellitus
Lung Diseases
Cardiovascular Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Heart Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Respiratory Tract Diseases
Nicotine
Ganglionic Stimulants
Autonomic Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Nicotinic Agonists
Cholinergic Agonists
Cholinergic Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action

ClinicalTrials.gov processed this record on July 26, 2017